日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Construction of a Three-Dimensional Calcific Aortic Valve Disease Model Using Human iPSC-Derived Valvular Interstitial Cells.

利用人诱导多能干细胞衍生的瓣膜间质细胞构建三维钙化性主动脉瓣疾病模型。

期刊:Stem Cell Reviews and Reports
影响因子:4.2
doi:10.1007/s12015-025-11030-3
Guo Ruikang, Qi Zhen, Qiu Ping, Mizrak Dogukan, Yang Bo
细胞生物学
发育与干细胞
Human
干细胞
发表日期：2026
文献求助 收藏

3D technology facilitates transoral endoscopic precision surgery of parapharyngeal space tumors

3D技术促进经口内镜精准手术治疗咽旁间隙肿瘤

期刊:Biomedical Engineering Online
影响因子:3.2
doi:10.1186/s12938-025-01469-3
Shi, Yue; Han, Shilong; Guo, Ruikang; Shi, Wenjie
3D/类器官
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Transcriptome analysis of induced pluripotent stem cells' osteogenic differentiation reveals NPY1R activating PI3K/AKT/mTOR in alveolar bone loss during periodontitis.

诱导多能干细胞成骨分化的转录组分析揭示了 NPY1R 在牙周炎期间牙槽骨丢失中激活 PI3K/AKT/mTOR。

期刊:American Journal of Translational Research
影响因子:1.6
doi:10.62347/CFCE7976
Li Xiaowen, Guo Ruikang, Liang Lingling, Liang Hao, Zhou Guangqi, Lu Qinglan, Huang Yonghui, Qi Zhen, Li Xiaojie
发育与干细胞
NPY
mTOR
干细胞
细胞生物学
AKT
发表日期：2025
文献求助 收藏

Machine learning-based analysis of risk factors for atrial fibrillation recurrence after Cox-Maze IV procedure in patients with atrial fibrillation and chronic valvular disease: A retrospective cohort study with a control group

基于机器学习的Cox-Maze IV手术后房颤复发风险因素分析：一项包含对照组的回顾性队列研究

期刊:Frontiers in Cardiovascular Medicine
影响因子:2.9
doi:10.3389/fcvm.2023.1140670
Jiang, Zenan; Song, Long; Liang, Chunshui; Zhang, Hao; Tan, Haoyu; Sun, Yaqin; Guo, Ruikang; Liu, Liming
发表日期：2023
文献求助 收藏

Clinical efficacy and safety of Cox-maze IV procedure for atrial fibrillation in patients with aortic valve calcification

Cox-maze IV手术治疗主动脉瓣钙化患者房颤的临床疗效和安全性

期刊:Frontiers in Cardiovascular Medicine
影响因子:2.9
doi:10.3389/fcvm.2023.1092068
Guo, Ruikang; Fan, Chengming; Sun, Zhishan; Zhang, Hao; Sun, Yaqin; Song, Long; Jiang, Zenan; Liu, Liming
发表日期：2023
文献求助 收藏

Dose approach matter? A meta-analysis of outcomes following transfemoral versus transapical transcatheter aortic valve replacement

剂量途径重要吗？经股动脉与经心尖途径经导管主动脉瓣置换术后疗效的荟萃分析

期刊:BMC Cardiovascular Disorders
影响因子:2.3
doi:10.1186/s12872-021-02158-4
Guo, Ruikang; Xie, Minghui; Yim, Wai Yen; Wu, Wenconghui; Jiang, Weiwei; Wang, Yin; Hu, Xingjian
发表日期：2021
文献求助 收藏

Bioprosthetic vs mechanical mitral valve replacement for infective endocarditis in patients aged 50 to 69 years

生物瓣膜与机械瓣膜二尖瓣置换术治疗50至69岁感染性心内膜炎患者的比较

期刊:Clinical Cardiology
影响因子:2.3
doi:10.1002/clc.23407
Hu, Xingjian; Jiang, Weiwei; Xie, Minghui; Guo, Ruikang; Yim, Wai Yen; Dong, Nianguo; Wang, Yin
炎症/感染
发表日期：2020
文献求助 收藏

Structural, electronic, magnetic, half-metallic, mechanical, and thermodynamic properties of the quaternary Heusler compound FeCrRuSi: A first-principles study

四元赫斯勒化合物FeCrRuSi的结构、电子、磁性、半金属性、力学和热力学性质：第一性原理研究

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-017-16324-2
Wang, Xiaotian; Khachai, Houari; Khenata, Rabah; Yuan, Hongkuan; Wang, Liying; Wang, Wenhong; Bouhemadou, Abdelmadjid; Hao, Liyu; Dai, Xuefang; Guo, Ruikang; Liu, Guodong; Cheng, Zhenxiang
发表日期：2017
文献求助 收藏

New Half-Metallic Materials: FeRuCrP and FeRhCrP Quaternary Heusler Compounds

新型半金属材料：FeRuCrP 和 FeRhCrP 四元赫斯勒化合物

期刊:Materials
影响因子:3.2
doi:10.3390/ma10121367
Ma, Jiannan; Feng, Liefeng; Guo, Ruikang; Liao, Yi; Khenata, Rabah; Liu, Guodong; Wang, Liying
发表日期：2017
文献求助 收藏